What is AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF used for?

AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF is indicated for Cancer (specific indication not clearly defined from abbreviations alone).

Who makes AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF?

AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF is developed by Shandong Cancer Hospital and Institute.

What development phase is AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF in?

AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF is in Phase 3.

What are the side effects of AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF?

Common side effects include Myelosuppression, Nausea and vomiting, Alopecia, Mucositis, Cardiotoxicity.

Last reviewed 2026-05-15 · How we verify

AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF

Shandong Cancer Hospital and Institute · Phase 3 active Small molecule

This is a chemotherapy regimen combining multiple cytotoxic agents to treat cancer by damaging DNA and inhibiting cell division.

This is a chemotherapy regimen combining multiple cytotoxic agents to treat cancer by damaging DNA and inhibiting cell division. Used for Cancer (specific indication not clearly defined from abbreviations alone).

At a glance

Generic name	AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF
Also known as	1.AC(doxorubicin/cyclophosphamide)-P(paclitaxel), 2.TEC(docetaxel/epirubicin/cyclophosphamide), 3.AC(doxorubicin/cyclophosphamide)-T(docetaxel), 4.TC(docetaxel/cyclophosphamide), 5.TCH(docetaxel/carboplatin/trastuzumab)
Sponsor	Shandong Cancer Hospital and Institute
Drug class	Chemotherapy regimen (combination)
Modality	Small molecule
Therapeutic area	Oncology
Phase	Phase 3

Mechanism of action

The regimen appears to be a combination of chemotherapy drugs (likely including anthracyclines, taxanes, and/or fluoropyrimidines based on the abbreviations) used in oncology. These agents work through different mechanisms—some intercalate DNA, others disrupt microtubules—to achieve synergistic cytotoxic effects against rapidly dividing cancer cells. The specific combination and dosing would be tailored to the cancer type being treated.

Approved indications

Cancer (specific indication not clearly defined from abbreviations alone)

Common side effects

Myelosuppression
Nausea and vomiting
Alopecia
Mucositis
Cardiotoxicity

Key clinical trials

Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF CI brief — competitive landscape report
AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF updates RSS · CI watch RSS
Shandong Cancer Hospital and Institute portfolio CI